首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1986232

全球DNA讀取、寫入與編輯市場

Global DNA Read, Write, and Edit Market

出版日期: 2026年03月10日 | 出版商:

BCC Research | 英文 142 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球DNA讀取、寫入和編輯市場規模預計將從2025年的259億美元成長到2030年的677億美元，2025年至2030年的複合年成長率為21.2%。

預計北美市場將從 2025 年的 112 億美元成長到 2030 年的 281 億美元，2025 年至 2030 年的複合年成長率為 20.2%。

預計亞太市場將從 2025 年的 60 億美元成長到 2030 年的 172 億美元，2025 年至 2030 年的複合年成長率為 23.4%。

本報告考察了全球 DNA 讀取、寫入和編輯市場，提供了概述、市場影響因素和機會分析、技術和專利趨勢、法律制度、歷史和預測市場規模、按各個細分市場和地區進行的詳細分析以及主要企業的概況。

概述
定序技術
桑格定序
第三代定序
基因合成過程
固相化學合成
基因組編輯技術
Meganucleases
鋅指核酸酶（ZFN）
轉錄活化因子樣效應核酸酶（TALENs）
CRISPR/CRISPR相關蛋白9（Cas9）
波特五力分析
宏觀經濟因素分析
美國關稅
地緣政治因素
醫療費用增加

第3章市場動態

市場動態
市場促進因素
對慢性病早期檢測的需求日益成長
感染疾病傳播加劇
基因組編輯領域的私人資金投入增加
市場限制因素
複雜且不斷變化的監管環境
定序分析設備高成本
CRISPR技術的脫靶效應
市場機遇
擴大基因組編輯的臨床應用範圍
在植物和牲畜育種的應用
下一代CAR-T療法的研發

第4章監管情勢

基因組編輯的調控通路
北美洲
EU
亞太地區
世界其他地區的監管狀況

第5章新興技術

重點
新興技術
定序技術的進步
CRISPR的體內遞送
基於 CRISPR 的診斷方法
人工智慧在DNA數據分析的應用

第6章市場區隔分析

細分市場
市場分析：按技術分類
重點
DNA讀取（定序分析）
DNA編碼（合成）
DNA編輯（基因組編輯）
市場分析：按應用領域
重點
臨床
研究
應用
按地區分類
市場分析：按地區分類
重點
北美洲
歐洲
亞太地區
世界其他地區

第7章競爭訊息

重點
產業結構
DNA讀取市場競爭分析
戰略分析
資金籌措前景

第8章：DNA閱讀、寫作和編輯市場的永續性：ESG觀點

ESG概覽
DNA讀取、寫入和編輯產業的ESG實踐
環境績效
ESG風險評估
結論

第9章附錄

調查方法
資訊來源
首字母縮寫詞
公司簡介
AGILENT TECHNOLOGIES INC.
BEAM THERAPEUTICS
CHARLES RIVER LABORATORIES
EUROFINS GENOMICS
F. HOFFMANN-LA ROCHE LTD.
GENSCRIPT
ILLUMINA INC.
INTEGRATED DNA TECHNOLOGIES INC.
MERCK KGAA
OXFORD NANOPORE TECHNOLOGIES PLC.
PACBIO
QIAGEN
REVVITY
THERMO FISHER SCIENTIFIC INC.
VERTEX PHARMACEUTICALS INC.
新興Start-Ups公司/市場顛覆者

簡介目錄圖表

Product Code: BIO193B

The global market for DNA read, write, and edit was valued at $25.9 billion in 2025 and is estimated to reach $67.7 billion by 2030, at a compound annual growth rate (CAGR) of 21.2% from 2025 through 2030.

The North American market for DNA read, write, and edit was valued at $11.2 billion in 2025 and is estimated to reach $28.1 billion by 2030, at a CAGR of 20.2% from 2025 through 2030.

The Asia-Pacific market for DNA read, write, and edit was valued at $6 billion in 2025 and is estimated to reach $17.2 billion by 2030, at a CAGR of 23.4% from 2025 through 2030.

Report Scope

The scope of the global DNA read, write, and edit market study encompasses market size analysis, as well as a detailed examination of the competitive environment, market dynamics, ongoing research, and driving trends driving market growth. The market has been segmented based on technology, application, and region.

The report provides an overview of the global DNA read, write, and edit market, analyzing market trends. It includes global revenue ($ Million) for the base year 2024 and estimated data for the forecast period 2025 through 2030.

The report covers the total market for DNA read, write, and edit, which includes DNA sequencing, DNA writing, and gene editing. Applications for these products in clinical, research, and other applied areas are also included in the report. The report also focuses on the regional segmentation of the market. The regions covered in this study include North America, Europe, the Asia-Pacific, and the Rest of the World, with a focus on major countries in these regions.

The report focuses on the major driving trends and challenges that affect the market and vendor landscape. It analyzes environmental, social, and corporate governance (ESG) developments and emerging technologies related to the market. It also covers a section on the regulatory landscape of the industry.

The report concludes with an analysis of the competitive landscape and industry structure. It also has a dedicated section of company profiles that covers details of leading companies in the market.

Report Includes

89 data tables and 59 additional tables
An overview of the global market for DNA read, write and edit technologies
In-depth analysis of global market trends, featuring historical revenue data for 2022-2024, estimated figures for 2025, as well as forecasts for 2030. This analysis includes projections of compound annual growth rates (CAGRs) through 2030
Evaluation of the current market size and revenue growth prospects specific to DNA read, write and edit technologies, accompanied by a market share analysis by technology, application, and region
Analysis of current and future demand in the global DNA read, write and edit technologies, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
Analysis of drivers, challenges, and opportunities affecting market growth
Information on sequencing technologies, market applications, industry structure, and important clinical sequencing initiatives
A look at the evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, and ESG trends of the market
Market share analysis of the key market participants, along with their research priorities, product portfolios, global rankings and company competitive landscape
Company profiles of major players within the industry, including Illumina Inc., Thermo Fisher Scientific Inc., QIAGEN, Oxford Nanopore Technologies plc., and BGI

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion

Chapter 2 Market Overview

Overview
Sequencing Technologies
Sanger Sequencing
Third-Generation Sequencing
Gene Synthesis Processes
Solid Phase Chemical Synthesis
Genome Editing Technologies
Meganucleases
Zinc Finger Nucleases (ZFNs)
Transcription Activator-like Effector Nucleases (TALENs)
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated Protein 9 (Cas9)
Porter's Five Forces Analysis in the DNA Read, Write, and Edit Market
Macroeconomic Factor Analysis
U.S. Tariffs
Geopolitical Factors
Increasing Healthcare Expenditures

Chapter 3 Market Dynamics

Market Dynamics
Market Drivers
Growing Need for Early Detection of Chronic Diseases
Increasing Prevalence of Infectious Diseases
Growing Private Funding for Genome Editing
Market Restraints
Complex and Evolving Regulatory Landscape
High Costs of Sequencing Instruments
Off-Target Impacts of CRISPR Technology
Market Opportunities
Expanding Clinical Applications of Genome Editing
Applications in Plant and Livestock Breeding
Development of Next-Generation CAR-T Therapies

Chapter 4 Regulatory Landscape

Regulatory Paths for Genome Editing
North America
Europe (EU)
Asia-Pacific
Regulatory Landscape Across the Rest of the World

Chapter 5 Emerging Technologies

Key Takeaways
Emerging Technologies
Advances in Sequencing Technologies
In Vivo Delivery of CRISPR
CRISPR-Based Diagnostics
Artificial Intelligence (AI) in DNA Data Analysis

Chapter 6 Market Segmentation Analysis

Segmentation Breakdown
Market Analysis by Technology
Key Takeaways
DNA Read (Sequencing)
DNA Write (Synthesis)
DNA Edit (Genome Editing)
Market Analysis by Application
Key Takeaways
Clinical Applications
Research
Applied
Geographic Breakdown
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
Rest of the World

Chapter 7 Competitive Intelligence

Key Takeaways
Industry Structure
Competitive Analysis of the DNA Read Market
Strategic Analysis
Funding Outlook

Chapter 8 Sustainability in the DNA Read, Write, and Edit Market: An ESG Perspective

Introduction to ESG
ESG Practices in the DNA Read, Write, and Edit Industry
Environmental Performance
ESG Risk Ratings
Conclusion

Chapter 9 Appendix

Methodology
Sources
Acronyms
Company Profiles
AGILENT TECHNOLOGIES INC.
BEAM THERAPEUTICS
CHARLES RIVER LABORATORIES
EUROFINS GENOMICS
F. HOFFMANN-LA ROCHE LTD.
GENSCRIPT
ILLUMINA INC.
INTEGRATED DNA TECHNOLOGIES INC.
MERCK KGAA
OXFORD NANOPORE TECHNOLOGIES PLC.
PACBIO
QIAGEN
REVVITY
THERMO FISHER SCIENTIFIC INC.
VERTEX PHARMACEUTICALS INC.
Emerging Startups/ Market Disruptors

簡介目錄圖表

List of Tables

Summary Table : Global DNA Read, Write, and Edit Market, by Region, Through 2030
Table 1 : DNA Read, Write, and Edit Technology Overview
Table 2 : Asia-Pacific: Regulatory Landscape
Table 3 : RoW: Regulatory Landscape
Table 4 : Global DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 5 : Global DNA Read Market, by Region, Through 2030
Table 6 : Global DNA Read Market, by Product and Service Type, Through 2030
Table 7 : Global DNA Read Consumables Market, by Region, Through 2030
Table 8 : Sequencing Consumables Offered by Major Companies
Table 9 : Global DNA Read Instruments Market, by Region, Through 2030
Table 10 : Sequencing Instruments Offered by Major Companies
Table 11 : Global DNA Read Software and Services Market, by Region, Through 2030
Table 12 : Global DNA Write Market, by Region, Through 2030
Table 13 : Global DNA Write Market, by Type, Through 2030
Table 14 : Global Gene Synthesis Market, by Region, Through 2030
Table 15 : Global Oligonucleotide Synthesis Market, by Region, Through 2030
Table 16 : Global DNA Edit Market, by Region, Through 2030
Table 17 : Global DNA Edit Market, by Editing Technology, Through 2030
Table 18 : Global CRISPR-based DNA Edit Market, by Region, Through 2030
Table 19 : Global TALEN-Based DNA Edit Market, by Region, Through 2030
Table 20 : Global ZFN-Based DNA Edit Market, by Region, Through 2030
Table 21 : Global Meganucleases-Based DNA Edit Market, by Region, Through 2030
Table 22 : Global DNA Read, Write, and Edit Market, by Application, Through 2030
Table 23 : Annual Occurrence Rate of Common Birth Defects in the U.S.
Table 24 : Global DNA Read, Write, and Edit Market for Clinical Applications, by Region, Through 2030
Table 25 : Global DNA Read, Write, and Edit Market for Research Applications, by Region, Through 2030
Table 26 : Global DNA Read, Write, and Edit Market for Applied Applications, by Region, Through 2030
Table 27 : Global DNA Read, Write, and Edit Market, by Region, Through 2030
Table 28 : North American DNA Read, Write, and Edit Market, by Country, Through 2030
Table 29 : North American DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 30 : North American DNA Read Market, by Product and Service Type, Through 2030
Table 31 : North American DNA Write Market, by Type, Through 2030
Table 32 : North American DNA Edit Market, by Editing Technology, Through 2030
Table 33 : North American DNA Read, Write, and Edit Market, by Application, Through 2030
Table 34 : U.S. DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 35 : U.S. DNA Read, Write, and Edit Market, by Application, Through 2030
Table 36 : Canadian DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 37 : Canadian DNA Read, Write, and Edit Market, by Application, Through 2030
Table 38 : Mexican DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 39 : Mexican DNA Read, Write, and Edit Market, by Application, Through 2030
Table 40 : European DNA Read, Write, and Edit Market, by Country, Through 2030
Table 41 : European DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 42 : European DNA Read Market, by Product and Service Type, Through 2030
Table 43 : European DNA Write Market, by Type, Through 2030
Table 44 : European DNA Edit Market, by Editing Technology, Through 2030
Table 45 : European DNA Read, Write, and Edit Market, by Application, Through 2030
Table 46 : German DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 47 : German DNA Read, Write, and Edit Market, by Application, Through 2030
Table 48 : U.K. DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 49 : U.K. DNA Read, Write, and Edit Market, by Application, Through 2030
Table 50 : French DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 51 : French DNA Read, Write, and Edit Market, by Application, Through 2030
Table 52 : Italian DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 53 : Italian DNA Read, Write, and Edit Market, by Application, Through 2030
Table 54 : Spanish DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 55 : Spanish DNA Read, Write, and Edit Market, by Application, Through 2030
Table 56 : Rest of Europe DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 57 : Rest of Europe DNA Read, Write, and Edit Market, by Application, Through 2030
Table 58 : Asia-Pacific DNA Read, Write, and Edit Market, by Country, Through 2030
Table 59 : Asia-Pacific DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 60 : Asia-Pacific DNA Read Market, by Product and Service Type, Through 2030
Table 61 : Asia-Pacific DNA Write Market, by Type, Through 2030
Table 62 : Asia-Pacific DNA Edit Market, by Editing Technology, Through 2030
Table 63 : Asia-Pacific DNA Read, Write, and Edit Market, by Application, Through 2030
Table 64 : Chinese DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 65 : Chinese DNA Read, Write, and Edit Market, by Application, Through 2030
Table 66 : Japanese DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 67 : Japanese DNA Read, Write, and Edit Market, by Application, Through 2030
Table 68 : South Korean DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 69 : South Korean DNA Read, Write, and Edit Market, by Application, Through 2030
Table 70 : Indian DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 71 : Indian DNA Read, Write, and Edit Market, by Application, Through 2030
Table 72 : Australian DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 73 : Australian DNA Read, Write, and Edit Market, by Application, Through 2030
Table 74 : Rest of Asia-Pacific DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 75 : Rest of Asia-Pacific DNA Read, Write, and Edit Market, by Application, Through 2030
Table 76 : RoW DNA Read, Write, and Edit Market, by Sub-region, Through 2030
Table 77 : RoW DNA Read, Write, and Edit Market, by Technology, Through 2030
Table 78 : RoW DNA Read Market, by Product and Service Type, Through 2030
Table 79 : RoW DNA Write Market, by Type, Through 2030
Table 80 : RoW DNA Edit Market, by Editing Technology, Through 2030
Table 81 : RoW DNA Read, Write, and Edit Market, by Application, Through 2030
Table 82 : Competitive Ranking of the DNA Read Market
Table 83 : Recent Developments in the DNA Read, Write, and Edit Market, 2023-2025
Table 84 : Key Investment Deals in the DNA Read, Write, and Edit Industry, 2024 and 2025
Table 85 : Environmental Performance Initiatives in the DNA Read, Write, and Edit Market
Table 86 : Social Performance Initiatives in the DNA Read, Write, and Edit Market
Table 87 : Governance Performance Initiatives in the DNA Read, Write, and Edit Market
Table 88 : ESG Risk Rankings for DNA Read, Write, and Edit Companies, 2025
Table 89 : Report Information Sources
Table 90 : Abbreviations Used in the Global DNA Read, Write, and Edit Market
Table 91 : Agilent Technologies Inc.: Company Snapshot
Table 92 : Agilent Technologies Inc.: Financial Performance, FY 2024 and 2025
Table 93 : Agilent Technologies Inc.: Product Portfolio
Table 94 : Agilent Technologies Inc.: News/Key Developments, 2024 and 2025
Table 95 : Beam Therapeutics: Company Snapshot
Table 96 : Beam Therapeutics: Financial Performance, FY 2023 and 2024
Table 97 : Beam Therapeutics: Product Portfolio
Table 98 : Beam Therapeutics: News/Key Developments, 2023
Table 99 : Charles River Laboratories: Company Snapshot
Table 100 : Charles River Laboratories: Financial Performance, FY 2023 and 2024
Table 101 : Charles River Laboratories: Product Portfolio
Table 102 : Eurofins Genomics: Company Snapshot
Table 103 : Eurofins Genomics: Product Portfolio
Table 104 : Eurofins Genomics: News/Key Developments, 2024
Table 105 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 106 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2023 and 2024
Table 107 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 108 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2023-2025
Table 109 : GenScript: Company Snapshot
Table 110 : GenScript: Financial Performance, FY 2023 and 2024
Table 111 : GenScript: Product Portfolio
Table 112 : GenScript: News/Key Developments, 2024 and 2025
Table 113 : Illumina Inc.: Company Snapshot
Table 114 : Illumina Inc.: Financial Performance, FY 2023 and 2024
Table 115 : Illumina Inc.: Product Portfolio
Table 116 : Illumina Inc.: News/Key Developments, 2025
Table 117 : Integrated DNA Technologies Inc.: Company Snapshot
Table 118 : Integrated DNA Technologies Inc.: Product Portfolio
Table 119 : Integrated DNA Technologies Inc.: News/Key Developments, 2023
Table 120 : Merck KGaA: Company Snapshot
Table 121 : Merck KGaA: Financial Performance, FY 2023 and 2024
Table 122 : Merck KGaA: Product Portfolio
Table 123 : Merck KGaA: News/Key Developments, 2025
Table 124 : Oxford Nanopore Technologies plc.: Company Snapshot
Table 125 : Oxford Nanopore Technologies plc.: Financial Performance, FY 2023 and 2024
Table 126 : Oxford Nanopore Technologies plc.: Product Portfolio
Table 127 : Oxford Nanopore Technologies plc.: News/Key Developments, 2024 and 2025
Table 128 : PacBio: Company Snapshot
Table 129 : PacBio: Financial Performance, FY 2023 and 2024
Table 130 : PacBio: Product Portfolio
Table 131 : PacBio: News/Key Developments, 2025
Table 132 : QIAGEN: Company Snapshot
Table 133 : QIAGEN: Financial Performance, FY 2023 and 2024
Table 134 : QIAGEN: Product Portfolio
Table 135 : QIAGEN: News/Key Developments, 2025
Table 136 : Revvity: Company Snapshot
Table 137 : Revvity: Financial Performance, FY 2023 and 2024
Table 138 : Revvity: Product Portfolio
Table 139 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 140 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
Table 141 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 142 : Thermo Fisher Scientific Inc.: News/Key Developments, 2024
Table 143 : Vertex Pharmaceuticals Inc.: Company Snapshot
Table 144 : Vertex Pharmaceuticals Inc.: Financial Performance, FY 2023 and 2024
Table 145 : Vertex Pharmaceuticals Inc.: Product Portfolio
Table 146 : Vertex Pharmaceuticals Inc.: News/Key Developments, 2023 and 2024
Table 147 : List of a Few Emerging Startups

List of Figures

Summary Figure : Global DNA Read, Write, and Edit Market Shares, by Region, 2024
Figure 1 : Porter's Five Forces Analysis: DNA Read, Write, and Edit Market
Figure 2 : Market Dynamics of Global DNA Read, Write, and Edit
Figure 3 : Emerging Technologies in the DNA Read, Write, and Edit Market
Figure 4 : Global DNA Read, Write, and Edit Market Shares, by Technology, 2024
Figure 5 : Global DNA Read Market Shares, by Product and Service Type, 2024
Figure 6 : Global DNA Write Market Shares, by Type, 2024
Figure 7 : Global DNA Edit Market Shares, by Editing Technology, 2024
Figure 8 : Global DNA Read, Write, and Edit Market Shares, by Application, 2024
Figure 9 : Global DNA Read, Write, and Edit Market Shares, by Region, 2024
Figure 10 : North American DNA Read, Write, and Edit Market Shares, by Country, 2024
Figure 11 : European DNA Read, Write, and Edit Market Shares, by Country, 2024
Figure 12 : Asia-Pacific DNA Read, Write, and Edit Market Shares, by Country, 2024
Figure 13 : RoW DNA Read, Write, and Edit Market Shares, by Sub-region, 2024
Figure 14 : Key ESG Metrics of DNA Read, Write, and Edit Companies
Figure 15 : Agilent Technologies Inc.: Revenue Shares, by Business Unit, FY 2025
Figure 16 : Agilent Technologies Inc.: Revenue Shares, by Country/Region, FY 2025
Figure 17 : Charles River Laboratories: Revenue Shares, by Business Unit, FY 2024
Figure 18 : Charles River Laboratories: Revenue Shares, by Country/Region, FY 2024
Figure 19 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Business Unit, FY 2024
Figure 20 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Country/Region, FY 2024
Figure 21 : GENSCRIPT: Revenue Shares, by Business Unit, FY 2024
Figure 22 : GENSCRIPT: Revenue Shares, by Country/Region, FY 2024
Figure 23 : Illumina Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 24 : Merck KGaA: Revenue Shares, by Business Unit, FY 2024
Figure 25 : Merck KGaA: Revenue Shares, by Country/Region, FY 2024
Figure 26 : Oxford Nanopore Technologies plc.: Revenue Shares, by Country/Region, FY 2024
Figure 27 : PACBIO: Revenue Shares, by Country/Region, FY 2024
Figure 28 : QIAGEN: Revenue Shares, by Business Unit, FY 2024
Figure 29 : QIAGEN: Revenue Shares, by Country/Region, FY 2024
Figure 30 : Revvity: Revenue Shares, by Business Unit, FY 2024
Figure 31 : Revvity: Revenue Shares, by Country/Region, FY 2024
Figure 32 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 33 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 34 : Vertex Pharmaceuticals Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 35 : Vertex Pharmaceuticals Inc.: Revenue Shares, by Country/Region, FY 2024